Targeting the RNA m6A modification for cancer immunotherapy
Abstract N 6-methyladenosine (m6A) is the most abundant epigenetic modification of RNA,
and its dysregulation drives aberrant transcription and translation programs that promote …
and its dysregulation drives aberrant transcription and translation programs that promote …
Gut microbiota metabolites in major depressive disorder—Deep insights into their pathophysiological role and potential translational applications
MA Ortega, MA Alvarez-Mon, C García-Montero… - Metabolites, 2022 - mdpi.com
The gut microbiota is a complex and dynamic ecosystem essential for the proper functioning
of the organism, affecting the health and disease status of the individuals. There is …
of the organism, affecting the health and disease status of the individuals. There is …
Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis
S Chen, L Zhang, M Li, Y Zhang, M Sun, L Wang… - Nature …, 2022 - nature.com
Microbiota-host interactions play critical roles in colorectal cancer (CRC) progression,
however, the underlying mechanisms remain elusive. Here, we uncover that Fusobacterium …
however, the underlying mechanisms remain elusive. Here, we uncover that Fusobacterium …
RNA methyltransferase METTL16: Targets and function
Abstract The N6‐methyladenosine (m6A) RNA methyltransferase METTL16 is an emerging
player in the RNA modification landscape of the human cell. Originally thought to be a …
player in the RNA modification landscape of the human cell. Originally thought to be a …
Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma
Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a wide
spectrum of liver injuries, ranging from hepatic steatosis, metabolic dysfunction-associated …
spectrum of liver injuries, ranging from hepatic steatosis, metabolic dysfunction-associated …
N6-methyladenosine RNA modification in inflammation: roles, mechanisms, and applications
J Luo, T Xu, K Sun - Frontiers in cell and developmental biology, 2021 - frontiersin.org
N6-methyladenosine (m6A) is the most prevalent internal mRNA modification. m6A can be
installed by the methyltransferase complex and removed by demethylases, which are …
installed by the methyltransferase complex and removed by demethylases, which are …
[HTML][HTML] A new model of spontaneous colitis in mice induced by deletion of an RNA m6A methyltransferase component METTL14 in T cells
Background and aims Mouse models of colitis have been used to study the pathogenesis of
inflammatory bowel disease (IBD) and for pre-clinical development of therapeutic agents …
inflammatory bowel disease (IBD) and for pre-clinical development of therapeutic agents …
Epitranscriptomic regulation by m6A RNA methylation in brain development and diseases
Cellular RNAs are pervasively tagged with diverse chemical moieties, collectively called
epitranscriptomic modifications. The methylation of adenosine at N6 position generates N6 …
epitranscriptomic modifications. The methylation of adenosine at N6 position generates N6 …
Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in …
K Liu, X He, J Huang, S Yu, M Cui, M Gao, L Liu… - Clinical …, 2023 - Springer
Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder characterized by
chronic low-grade inflammation. Previous studies have demonstrated that the gut …
chronic low-grade inflammation. Previous studies have demonstrated that the gut …
Dissecting the interplay mechanism between epigenetics and gut microbiota: health maintenance and disease prevention
Y Wu, CZ Wang, JY Wan, H Yao, CS Yuan - International Journal of …, 2021 - mdpi.com
The gut microbiota exists throughout the full life cycle of the human body, and it has been
proven to have extensive impacts on health and disease. Accumulating evidence …
proven to have extensive impacts on health and disease. Accumulating evidence …